Home › Chronic Lymphocytic Leukemia › Texas › Dallas
Pag-aaral pangklinika para sa Chronic Lymphocytic Leukemia sa Dallas, TX
Isang pag-aaral para sa Chronic Lymphocytic Leukemia ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Dallas. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)
Nagre-recruitPhase 3
- Texas Oncology Baylorcharles A Sammons Cancer Center, Dallas
Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)
Nagre-recruitPhase 1
- Baylor University Medical Center, Dallas
Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML
Nagre-recruitPhase 1/2
- Baylor Scott & White Health, Dallas
A Study of Lonitoclax (ZE50-0134) in Relapsed or Refractory B-cell Malignancies
Nagre-recruitPhase 1
- UT Southwestern Medical Center, Dallas
A Study of Emavusertib + An Approved Bruton Tyrosine Kinase Inhibitor (BTKi) in Participants With Chronic Lymphocytic Leukemia (CLL) and Other B-cell Malignancies
Nagre-recruitPhase 2
- Texas Oncology - Sammons Cancer Center, Dallas
The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
Nagre-recruitPhase 1/2
- University of Texas(UT) Southwestern-Children's Medical Center, Dallas
A Study to Evaluate the Risk of Tumor Lysis Syndrome (TLS) in Adult Participants Receiving Oral Venetoclax in Combination With Intravenously Infused Obinutuzumab or Oral Acalabrutinib for Previously Untreated Chronic Lymphocytic Leukemia (CLL)
Nagre-recruitPhase 3
- University of Texas - Southwestern Medical Center /ID# 266528, Dallas
Study of SGR-1505 in Mature B-Cell Neoplasms
Nagre-recruitPhase 1
- University of Texas Southwestern, Dallas
A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies
Nagre-recruitPhase 1
- University of Texas Southwestern Medical Center, Dallas
Safety and Efficacy of KRT-232 in Combination With Acalabrutinib in Subjects With R/R DLBCL or R/R CLL
Nagre-recruitPhase 1/2
- UT Southwestern Medical Center, Dallas
Pag-aaral para sa Chronic Lymphocytic Leukemia sa ibang lungsod
- Boston, MA31 pag-aaral
- Columbus, OH29 pag-aaral
- Durham, NC27 pag-aaral
- Washington, DC22 pag-aaral
- Seattle, WA21 pag-aaral
- Rochester, MN19 pag-aaral
- New York City, NY18 pag-aaral
- Houston, TX17 pag-aaral
- Baldwin Park, CA16 pag-aaral
- Milwaukee, WI14 pag-aaral
- Chicago, IL14 pag-aaral
- Cincinnati, OH14 pag-aaral
Iba pang pag-aaral sa Dallas
- Kanser sa Suso54 pag-aaral
- Non-Small Cell Lung Cancer52 pag-aaral
- Pagkabigo ng Puso42 pag-aaral
- Metastatic Cancer42 pag-aaral
- Kanser (lahat ng uri)38 pag-aaral
- Kanser sa Prostate36 pag-aaral
- Colorectal Cancer33 pag-aaral
- Obesity31 pag-aaral
- Kanser sa Ovary28 pag-aaral
- Kanser sa Pantog27 pag-aaral
- Kanser sa Baga27 pag-aaral
- Kanser ng Endometrium25 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 1, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.